These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes. Hartard M; Kleinmond C; Kirchbichler A; Jeschke D; Wiseman M; Weissenbacher ER; Felsenberg D; Erben RG Bone; 2004 Oct; 35(4):836-41. PubMed ID: 15454090 [TBL] [Abstract][Full Text] [Related]
7. Flow-mediated dilation in athletes: influence of aging. Montero D; Padilla J; Diaz-Cañestro C; Muris DM; Pyke KE; Obert P; Walther G Med Sci Sports Exerc; 2014 Nov; 46(11):2148-58. PubMed ID: 24963792 [TBL] [Abstract][Full Text] [Related]
8. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629 [TBL] [Abstract][Full Text] [Related]
9. Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance. Rickenlund A; Thorén M; Nybacka A; Frystyk J; Hirschberg AL Hum Reprod; 2010 Jan; 25(1):85-93. PubMed ID: 19840988 [TBL] [Abstract][Full Text] [Related]
10. Is there an association between athletic amenorrhea and endothelial cell dysfunction? Zeni Hoch A; Dempsey RL; Carrera GF; Wilson CR; Chen EH; Barnabei VM; Sandford PR; Ryan TA; Gutterman DD Med Sci Sports Exerc; 2003 Mar; 35(3):377-83. PubMed ID: 12618566 [TBL] [Abstract][Full Text] [Related]
11. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel. Teichmann A Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257 [TBL] [Abstract][Full Text] [Related]
12. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids. Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162 [TBL] [Abstract][Full Text] [Related]
13. The effect of oral contraceptives on bone mass and stress fractures in female runners. Cobb KL; Bachrach LK; Sowers M; Nieves J; Greendale GA; Kent KK; Brown BW; Pettit K; Harper DM; Kelsey JL Med Sci Sports Exerc; 2007 Sep; 39(9):1464-73. PubMed ID: 17805075 [TBL] [Abstract][Full Text] [Related]
14. [Influence of progestins on adverse effects of oral contraceptives]. Wynn V Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210 [TBL] [Abstract][Full Text] [Related]
15. The use of low dose oral contraceptives for the management of acne. Lemay A; Langley RG Skin Therapy Lett; 2002 Dec; 7(10):1-5. PubMed ID: 12658330 [TBL] [Abstract][Full Text] [Related]
16. Pulsatile luteinizing hormone patterns in long term oral contraceptive users. Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046 [TBL] [Abstract][Full Text] [Related]
17. Effect of passive smoking on endothelial function in: healthy adults. Holay MP; Paunikar NP; Joshi PP; Sahasrabhojney VS; Tankhiwale SR J Assoc Physicians India; 2004 Feb; 52():114-7. PubMed ID: 15656044 [TBL] [Abstract][Full Text] [Related]
19. Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus. Sidhu JS; Cowan D; Kaski JC Am J Cardiol; 2004 Jul; 94(2):151-6. PubMed ID: 15246889 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen. Sitruk-Ware RL; Menard J; Rad M; Burggraaf J; de Kam ML; Tokay BA; Sivin I; Kluft C Contraception; 2007 Jun; 75(6):430-7. PubMed ID: 17519148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]